Introduction
Processed copies of genes, initially found in mammals because of their abundance (Wagner 1986 ), are present in many organisms (Mighell et al. 2000) . The amount of processed genes in mammalian genomes is remarkable. For example, 545 genes have been described, and 134 pseudogenes have been claimed in human chromosome 22. Eighty-two percent of these pseudogenes are intronless processed copies that originate via retroposition from known genes (Dunham et al. 1999) . In human chromosome 21, 225 genes have been described, and 59 pseudogenes have been found with many of them being processed copies (Hattori et al. 2000) . Given that the human genome contains 30,000-40,000 genes (Lander et al. 2001; Venter et al. 2001 ), the amount of processed genes in the human genome (Gonçalves, Duret, and Mouchiroud 2000) is estimated to be between 10,000 and 14,000.
Processed genes have been experimentally generated in human cells by Maestre et al. (1995) . In the experimental work of Maestre and co-workers, mRNAs are reverse transcribed and integrated in the human genome. The processed gene made by the integrated sequence has the length of the mRNA of the original gene, possesses a poly-A tail and, often, direct flanking repeats. Many of these processed genes found in organisms have traits that preclude their functionality and thus are pseudogenes; however, more and more cases of functional processed copies of genes are accumulating (see Brosius 1999 for a review). Two well-studied instances in humans are Pyruvate dehydrogenase 2 (Pdha2) and Phosphoglycerate kinase 2 (Pgk-2). Both Pdha2 and Pgk-2 are intronless autosomal copies of Pdha1 and Pgk-1, respectively. Pdha1 and Pgk-1 are intron-containing genes located in the X chromosome. The original parental copies, in both cases, have a constitutive function, but their presence at the X chromosome prevents them from being expressed in the testis because of X-inactivation. Unlike Pdha1 and Pgk-1, Pdha2 and Pgk-2 are expressed only in the testis. Pdha2 and Pgk-2 have 86% and 87% identity at the protein level, respectively, with the parental gene and maintain similar function (McCarrey and Tomas 1987; Dahl et al. 1990; Fitzgerald et al. 1996; McCarrey et al. 1996) . The Pdha2-promoter region is derived from a recent retroposon insertion from Pdha1 gene (Datta et al. 1999) , whereas the Pgk-2-promoter region arose originally from a rare aberrant transcript that included the promoter region of Pgk-1 (McCarrey 1987) .
Hence, processed genes are common in humans, and many of them are likely to be functional. How do we know whether or not a processed gene is functional from available sequence data? The neutral theory of molecular evolution (Kimura 1983, p. 178) predicts that pseudogenes should evolve as a neutral sequence (Li, Gojobori, and Nei 1981) . They should change with time at an even substitution rate across the whole sequence. Flanking and coding sequences should show the same evolutionary patterns. In addition, and as a consequence of this, stop codons are likely to appear (Li 1997, p. 347) . Synonymous substitutions per synonymous site (K S ) and nonsynonymous substitutions per nonsynonymous site (K A ) should be equivalent. Thus, the K A /K S ratio of pseudogenes is expected to be equal to one (Miyata and Hayashida 1981; Kimura 1983) . Similarly, if we look at the first, second, and third codon positions since the pseudogene formation, rates of divergence for every one of these positions should also be equal (Li, Gojobori, and Nei 1981 will show a high level of polymorphism and divergence along the whole region because levels of diversity inversely correlate with level of biological constraint. The analysis of polymorphism and divergence for a processed gene can give important insights complementary to functional studies (e.g., expression).
Here, we report that a Phosphoglycerate mutase processed gene (PGAM3) in primates evolved as a new functional gene. PGAM3 had so far been only found in humans, and it was described as a pseudogene: Phosphoglycerate mutase 1 processed pseudogene (-PGAM1; Dierick, Mercer, and Glover 1997) . However, our data reveal its functionality, and we suggest naming this newly found functional processed gene as Phosphoglycerate mutase 3 (PGAM3). PGAM3 originated by retrotransposition, as suggested by its several molecular features. The parental gene, phosphoglycerate mutase brain isoform gene (PGAM1), is an intron-containing gene with a coding region of 762 bp, a 5Ј untranslated region (UTR) of 12 bp, and a 3ЈUTR of 912 bp (Dierick, Mercer, and Glover 1997; Lander et al. 2001) , and it is located on chromosome 10, 10q25.3 (Dierick, Mercer, and Glover 1997; Lander et al. 2001) . However, PGAM3 is intronless, and it is located in the first intron of the Menkes disease gene (MNK) in the X chromosome region Xq13.3 (Dierick, Mercer, and Glover 1997) . This position is different from the PGAM1 location, and note that it is inserted within the coding region of another gene. PGAM3 homology with PGAM1 includes 3Ј and 5ЈUTR (Dierick, Mercer, and Glover 1997) . PGAM3 has a poly-A tail 16 bp after the polyadenylation signal at the end of the 3ЈUTR and is flanked by 10 bp direct repeats (Dierick, Mercer, and Glover 1997) , as expected from a processed gene (Vanin 1985; Maestre et al. 1995; Mighell et al. 2000) . All these features were revealed in an earlier analysis by Dierick, Mercer, and Glover (1997) . We have found PGAM3 in chimpanzee and macaque. We have investigated polymorphism in human populations and examined the expression of this gene. Our data support the functionality of PGAM3. These results are discussed considering published information about the genomic region and how pseudogenes evolve.
Materials and Methods

DNA Samples and Sequencing
The PGAM3 gene in human (Homo sapiens) and chimpanzee (Pan troglodytes) was amplified by PCR from genomic DNA. Primers were designed to amplify this gene sequence specifically. A 5Ј primer was located in the second exon of the Menkes disease gene (MNK or ATP7A gene), 5Ј-CACCATTCACTTTTCCAATC-3Ј, and a 3Ј primer was located in the 3ЈUTR of PGAM3, maximizing mismatches with the PGAM1 copy, 5Ј-AC-ATCACCATGCAGATTACATTCA-3Ј ( fig. 1 ). For some individuals, nested primers (5Ј-CAATCTGCTGC-TCAATGGTC-3Ј and 5Ј-CTAGAGCCCCCAGGCAG-TGG-3Ј) designed in the same regions were used to reamplify ( fig. 1 ). The PGAM3 coding regions of 15 human males, representing all continents, and a chimpanzee male sample were sequenced (see table 1 for details on the origin of the samples). Partial coding sequence (324 bp) was obtained in a macaque male (Macaca mulata) using primers flanking PGAM3 coding region (5Ј-AGGGAATAAGGGTGGGAAAAAGAAT-3Ј and 5Ј-ACATCACCATGCAGATTACATTCA-3Ј). Haplotypes were determined directly by sequencing both strands from every individual, except for macaque in which only primers in one direction produced high quality sequence.
Sequence Analysis
Sequences were aligned by means of Clustal W (Thompson, Higgins, and Gibson 1994) and manually adjusted. Corrected number of synonymous and nonsynonymous substitutions per site (K S and K A ) were computed following the method described by Kumar (Nei and Kumar 2000, p. 64 ) and using MEGA2 software . This method corrects for multiple hits, treating arginine and isoleucine codons accurately . Standard errors (SEs) were computed analytically, according to Nei and Kumar (2000) . In a rough scale, the K A /K S ratio is assumed to be equal to one under the neutral model, smaller than one under purifying selection, and greater than one under positive selection (Kimura 1983) . The difference between K A and K S was tested using the normal deviate or Z test . This test relies on substitutions being normally distributed. D ϭ K A Ϫ K S and its SE (SE [D] ) to compute Z were obtained analytically using MEGA2. MEGA2 was also used to obtain the neighborjoining trees for K A and K S . Because the assumption of normal distribution for substitutions may not be met, we will further investigate the results of this comparison with the following different approaches.
Tajima's relative rate test (Tajima 1993 ) was performed for the first, second, and third codon position substitutions using MEGA2 . After pseudogene formation (see fig. 2 ), the sequence is supposed to evolve neutrally. The pseudogene lineage will show an accelerated rate of evolution because of the loss of constraint along the entire sequence. First, the rates of evolution among all the codon positions for a pseudogene should be similar (Li, Gojobori, and Nei 1981) . 
Human (Li, Gojobori, and Nei 1981) .
Comparison with an outgroup sequence, PGAM2 in this case (phosphoglycerate mutase muscle isoform gene; Dierick et al. 1995) , provides the necessary information to determine changes in each lineage using a parsimony criterion.
Using this information, we have designed a probability test for two hypotheses: (1) if PGAM3 is evolving as a pseudogene, i.e., all three codon positions evolve at the same rate, and (2) if PGAM3 is evolving as a constrained protein. We use the likelihood ratio test (Sokal and Rohlf 1995) on the trinomial probability of the number of nucleotide substitutions over codon positions under the two models and under observed sequence evolution. Trinomial distribution probability is computed: P(n 1 ,n 2 ,n 3 ) ϭ n!/(n 1 !n 2 !n 3 !)( ), where f 1 , f 2 , and f 3 n n n
are the frequencies and n 1 , n 2 , and n 3 are the numbers of the observed changes. Likelihood ratio test is n! n n n
where f 1 , f 2 , and f 3 are the observed frequencies and are the expected frequencies under the hyfЈ, fЈ, and fЈ pothesis (Sokal and Rohlf 1995) . G can be approximated by the chi-square distribution with as many degrees of freedom as cells minus one (Sokal and Rohlf 1995) . Nucleotide diversity, , defined as the average number of nucleotide differences per site between two random sequences (Tajima 1989) , and W , Watterson estimate of 3Ne from the number of segregating sites (Watterson 1975) , were calculated. Both values estimate the neutral parameter ϭ 3Ne for X-linked loci, where Ne is the effective population size and is the neutral mutation rate under equilibrium conditions. Deviations from equality of these values reveal nonequilibrium conditions in the history of the sample. Tajima's D (Tajima 1989) Fu and Li (1993) propose another test to measure departure from neutral expectations.
. They demonstrated that e , the total number of mutations in the external branches of a genealogy of n sequences, and i , the total number of mutations in the internal branches, can be used to estimate . External branches are known to be more affected by selection because recent mutations are close to the tips. Tajima's test (Tajima 1989) and Fu and Li's test with outgroup (1993) were carried out using the program DNAsp, Version 3.52 (Rozas and Rozas 1999) . Significance was tested by 10,000 coalescent simulations.
Expression Analysis
PCR from four human cDNA libraries (Human leukocyte 5Ј-stretch cDNA library from Clontech, Human testis 5Ј-strech plus cDNA library from Clontech, Human Tcell lambda cDNA library from Stratagene, and GEX5 Hela cDNA library of Fukunaga and Hunter 1997) was carried out with primers specific for PGAM3 (5Ј-CAGAAGATCAGCTACCCTCCTA-3Ј and 5Ј-AC-ATCACCATGCAGATTACATTCA-3Ј) and nested primers specific for PGAM3 (5Ј-CTACCCTCCTATGA-GAGTCC-3Ј and 5Ј-GGGCAGAGGGACAAGACCA-3Ј). Primers contain from 1 to 3 mismatches to the PGAM1 gene are shown in bold type. Specificity was achieved at 59ЊC using Expand High Fidelity Taq polymerase (Roche). Products were digested with BstXI to reveal that the amplified copy was PGAM3 (Dierick, Mercer and Glover 1997) . The BstXI restriction site is present in PGAM3 but not in PGAM1. In addition, products from these PCRs were sequenced to confirm the specificity of the amplification.
Results
Evolution of PGAM3 Coding Region
Complete sequence of the coding region was determined for human and chimpanzee samples. A summary of the variation between the sequences obtained in this work is shown in table 1. Only partial sequence was obtained for macaque (324 bp). Fixed differences between PGAM1 (original copy) and PGAM3 genes (positions 458, 572, 581, 589, 648, and 729) suggest that PGAM3 originated before cercopithecoidea-hominoidea split (table 1) . We include this sequence to illustrate the presence of PGAM3 in macaque but exclude it from the analysis because the sequence is partial. Human PGAM3 consensus sequence differs in two positions from the sequence reported by Dierick, Mercer, and Glover (1997) . Only partial sequence is available from human sequence draft (Lander et al. 2001) , and it is identical to the consensus in table 1. The difference in Dierick, Mercer, and Glover (1997) might be a rare polymorphism or a sequencing error.
Synonymous and nonsynonynous substitutions per site (K S and K A ) are shown in table 2. K S in a pairwise comparison between PGAM1 and PGAM3 was on an average 0.006. This value does not reveal high levels of divergence for this type of site. The average sequence divergence was 0.0124 Ϯ 0.0007 for the human and chimpanzee pair in a recent study of 24 kb of autosomal intergenic DNA segments (Chen and Li 2001) and ranged from 0.0026 to 0.0138 for noncoding regions of NOTE.-Consensus sequence for Human PGAM3 was used in these comparisons. K A (below diagonal) and K S (above diagonal) values are bold whenever there is a significant difference from one of the K A /K S ratio (P Ͻ 0.05). (Saitou and Nei 1987 ) using Kumar correction . MEGA 2.00 was used to compute and to display the phylogeny. Human PGAM2 was used as an outgroup in all the comparisons because it is believed to come from an earlier duplication than the one from which PGAM3 arises (Dierick, Mercer, and Glover 1997; Sakoda et al. 1988 ). Synonymous and nonsynonymous trees (in this order) are shown. 254 codons and consensus human PGAM3 were used in the comparisons. the X chromosome (see Przeworski, Hudson, and Di Rienzo 2000 for a review). The low K S values produce an unresolved tree ( fig. 3) . Given that PGAM3 is older than human-chimp divergence, 0.006 is not a high value as it would be expected if PGAM3 is evolving without constraint. K A values in the comparison of PGAM1 with PGAM3 are on an average 0.0205. This value is high compared with synonymous substitutions (see subsequently).
FIG. 3.-Synonymous and nonsynonymous neighbor-joining trees
A way to test for deviation of the neutral pattern is to compare synonymous and nonsynonymous changes per site that have accumulated since two sequences diverged from their common ancestor. Another way is to study whether all codon positions evolve at the same rate. We address both these aspects.
Under the neutral model, it is expected that K A equals K S (Kimura 1983 ). However, comparison of PGAM1 with human PGAM3 and chimpanzee PGAM3 showed K A to be greater than K S . K A /K S values were 2.625 and 5.000, respectively, with probabilities of 0.052 and 0.008. The ratio does reveal high levels of amino acid divergence but only in the PGAM3 lineage (see subsequently).
Comparison with an outgroup sequence, PGAM2, provides the necessary information to determine changes in each lineage using a parsimony criterion. Most of the nonsynonymous changes between PGAM1 and PGAM3 occurred in the PGAM3 lineage (see fig. 3 and table 3). The number of amino acid changes in this lineage was significantly higher than that in the lineage leading to PGAM1 (table 3): 1 versus 9 (P ϭ 0.011) in human and chimpanzee PGAM3 lineages. Changes occurred preferentially not only in the second codon position (see significant values in table 3) but also in the first codon position. These two codon positions together explain the significant difference in amino acid rate.
We tested whether or not the substitutions at the three codon positions of PGAM3 are consistent with the substitution pattern for a pseudogene. Do substitutions occur more often at the first and second codon positions than expected in a pseudogene? In a pseudogene, we expect f 1 ϩ f 2 ϭ 2f 3 . The probability of our observation in chimpanzee under this expectation is 0.0172. First and second positions appear to be evolving faster than expected in a pseudogene (unconstrained sequence), supporting the view that positive selection is acting in this gene changing amino acid composition.
We also tested whether or not the substitutions at the three codon positions are consistent with a general substitution pattern for common genes. A general substitution rate pattern for the three codon positions is f 3 Ͼ f 1 Ͼ f 2 (Li 1997) . In the particular case of globins, f 1 Ј ϭ 0.24, f 2 Ј ϭ 0.20, and f 3 Ј ϭ 0.56 (Kimura 1983 ). However, PGAM3 shows f 2 (0.600) Ͼ f 1 (0.400) Ͼ f 3 (0) in chimpanzee and f 2 (0.455) Ͼ f 1 (0.365) Ͼ f 3 (0.18) in human. The likelihood ratio tests for these two comparisons yield probabilities of 0.0002 and 0.0297, respectively. First and second positions are evolving faster than expected in a coding gene, again supporting the view that positive selection is acting on this gene.
Pseudogenes often have deletions and insertions (indel) in the coding region (Vanin 1985; Mighell et al. 2000) . However, this is not the case for PGAM3 in human and chimpanzee in which we sequenced the complete coding sequence (762 bp, table 1). There are no deletions in the partial sequence obtained for macaque either.
Why do we observe no indels in the coding region of PGAM3? A possibility is that the gene is too young to accumulate any indels. However, Dierick, Mercer, and Glover (1997) found nine indels and 18 bp changes in the 3ЈUTR of PGAM3 and 0 indels in the coding region when they sequenced the whole PGAM3 and compared this sequence with PGAM1 (Dierick, Mercer, and Glover 1997) . We have statistically compared coding versus UTR in the PGAM3 lineage. In the coding region, there are 11 mutations (table 3) . For the 3ЈUTR, there is no outgroup sequence that allows us to infer in what lineage the mutations occurred. We think that the 3ЈUTR is not as constrained as the coding region and that both PGAM3 and PGAM1 can accumulate changes in that region. Under this assumption that half of the changes in the 3ЈUTR occurred in the PGAM3 lineage, we can construct a two (indels-substitutions) by two (coding region-3ЈUTR) contingency table for PGAM3. Chi-square test probability under the observed pattern is 0.0267. This implies that both regions behaved differently. We would expect a similar distribution of the variation if PGAM3 were a pseudogene.
These analyses uncover the functionality of PGAM3 (1) functional constraint revealed by the absence of indels in the protein coding region, and (2) higher protein substitution rate than in a pseudogene and higher protein substitution rate than in a normal functional gene like globin genes, revealing the action of positive selection. Thus, we suggest that primate PGAM3 is a newly evolved functional gene encoding a rapidly evolving protein.
Levels of Polymorphism
PGAM3 polymorphism data in human are shown in table 1. Coding region of PGAM3 was sequenced for 15 human males from around the world. Only three segregating sites were observed in the human PGAM3. The three segregating sites are singletons, transitions, and produce replacement change. is 0.052% (SE ϭ 0.024%) and W is 0.121% (SE ϭ 0.078%). These values are low, but they do not differ from the diversity reported in normal human X-linked genes: of 0.000%-0.178% and W of 0.000%-0.148% (Li and Sadler 1991; Przeworski, Hudson, and Di Rienzo 2000) .
Tajima's D value for this data was negative: Ϫ1.68501 (P Ͻ 0.05). A negative value is caused by segregating sites at low frequency because rare alleles contribute less to than to W . Negative values are expected under exponential growth (Slatkin and Hudson 1991) or after a selective sweep, rapid fixation of a new allele (Braverman et al. 1995) . Fu and Li's D value using PGAM1 or chimpanzee PGAM3 as an outgroup was Ϫ2.39127 (P Ͻ 0.05). This negative value is again a consequence of the presence of segregating sites at low frequency. This is expected under rapid fixation of a new allele or exponential growth (Fu and Li 1993) . The high rate of amino acid substitution we observe in PGAM3 indicates that PGAM3 may have been under positive selection in the human lineage and could explain the observed pattern for the gene variation. Rapid fixation of new mutations could explain the observed polymorphism pattern (see Discussion).
Expression Analysis and Functionality
Given the data of the population genetics and other evolutionary studies that reveal functionality of PGAM3, we tested a few cDNA libraries for the expression of this gene. Figure 4A shows nested amplifications from these cDNA libraries. A band is produced from leukocyte cDNA library. This product was digested with BstXI restriction enzyme to reveal an amplified copy (Dierick, Mercer, and Glover 1997) . BstXI restriction site is present in PGAM3 but not in PGAM1. Undigested and digested products of this band are shown in figure  4B . This band was also sequenced reconfirming that it corresponds to PGAM3. The detected tissue-specific expression pattern suggests that the expression may be authentic.
Although no transcript was observed for this gene by Dierick, Mercer, and Glover (1997) , we observed the transcript when we used a different strategy. These authors tried to amplify this gene with primers that amplify both copies and after that digest with BstXI to reveal the presence of the new copy. This procedure could mask the low expression of the new copy because PGAM1 is very highly expressed in all the essayed tissues (data not shown). In our case we used two rounds of specific primers (see Materials and Methods). Interestingly, our observation of expression is consistent with a possible promoter (putative TATA box and CAAT box) already described by Dierick, Mercer, and Glover (1997) .
To infer the possible function of PGAM3, sequences of the putative human and chimpanzee PGAM3 were aligned ( fig. 5 ). Human PGAM3 consensus sequence is shown. PGAM proteins are dimeric glycolytic enzymes that catalyze the reaction from 2-phosphoglycerate to 3-phosphoglycerate (Grisolia and Joyce 1959; Grisolia and Carreras 1975) . Two isoforms have been described in mammals: PGAM-M (muscle specific form; PGAM2 in human) and PGAM-B (brain form; PGAM1 in human). Erythrocytes contain another related enzyme that catalyzes the conversion of 1,3-biphosphoglycerate in 2,3-biphosphoglycerate: the diphosphoglycerate mutase (DPGAM; Sakoda et al. 1988) . Figure 5 shows an alignment with these other related proteins. Amino acids known to be at the enzyme active site are outlined in bold type: His at position 11, Arg at position 62, and His at position 186 (Grisolia and Joyce 1959) . All of them remain intact in human, chimpanzee, and macaque PGAM3, revealing that PGAM3 can still keep PGAM function.
Discussion
Pseudogenes are defined as regions of DNA that are similar to functional genes, but various mutations do not allow the sequence to generate a functional product (Proundfoot and Maniatis 1980). As we reviewed earlier in the article (see Introduction), processed genes will often lack promoter and thus become silent functionless pseudogenes. Even so, some processed copies of genes can attain functionality through the acquisition of regulatory regions (Brosius 1999) . As of now, there are up to ϳ20 cases in which the functionality of the processed genes in humans has been demonstrated (Betrán and Long 2001) . Our data revealed a new primate processed gene, i.e., PGAM3, that originated by retroposition and evolved under positive Darwinian selection.
The Age of PGAM3 PGAM3 was first described to be a pseudogene present only in human beings. We have found PGAM3 in chimpanzee and macaque. This means that PGAM3 is older than originally proposed. According to its distribution, it is no less than 25 Myr old (Goodman et al. 1998 ).
PGAM3 Encoding a Functional Protein
Many features of PGAM3 evolutionary pattern support the finding that the gene is encoding for a functional protein. The coding region does not show deletions or insertions (or both) or nonsense mutations in human, chimpanzee, or macaque sequences reported in this work or previous work (Dierick, Mercer, and Glover 1997) , whereas many deletions took place in the 3ЈUTR, implying that the coding region is under certain constraint. Pseudogene evolution has been studied since the late-1970s. They often accumulate mutations at an accelerated rate compared with parental functional genes, indels, and nonsense mutations that destroy their function (Vanin 1985; Mighell et al. 2000) . For example, HLA-H is a pseudogene that arose by duplication in the human leukocyte antigen complex. It has a single base pair deletion in exon 4 that makes the gene nonfunctional (Grimsley, Mather, and Ober 1998) . This is not the case for PGAM3.
In addition, PGAM3 coding region evolution is not consistent with the neutral model proposed for unconstrained sequences. First, levels of amino acid divergence are higher than synonymous divergence when compared with that of the original copy PGAM1 in human and in chimpanzee. Amino acid changes are more rapid than synonymous changes in the PGAM3 lineage. Evolutionary changes occurred preferentially in the first and second codon positions. This supports the view that PGAM3 may have been under positive selection, rapid fixation of some amino acid changes. One usually expects the effect of positive selection at the amino acid level only if the gene is functional: i.e., translated.
Low Levels of Variation
Polymorphism within PGAM3 in humans is very low and is biased toward rare alleles; there are significant negative Tajima's D and negative Fu and Li's D. The neutral model under which one expects high levels of polymorphism and no frequency spectrum bias for pseudogenes, again, cannot interpret these results.
Negative values of Tajima's D and Fu and Li's D are expected under exponential growth (Slatkin and Hudson 1991) or after a selective sweep, rapid fixation of a new allele (Braverman et al. 1995) . Under exponential growth, one expects that every single locus of the genome will show negative Tajima's D. Three studies of 10 kb noncoding sequence in human have been carried out: Xq13.3 region (Kaessmann et al. 1999) , chromosome 22 (Zhao et al. 2000) , and chromosome 1 (Yu et al. 2001 ). Tajima's D values in these studies were Ϫ1.62 (P Ͼ 0.05), Ϫ1.03 (P Ͼ 0.10), and Ϫ1.22 (0.05 Ͻ P Ͻ 0.10), respectively (Kaessmann et al. 1999; Zhao et al. 2000; Yu et al. 2001) . All values were negative but not significant. The study of polymorphism of Xq13.3 was carried out in a region of very low recombination (1.3 cM/Mb) and has recently been reviewed (Zhao et al. 2000) . It showed a significant Tajima's D and Fu and Li's D test: Ϫ1.57 (P Ͻ 0.03) and Ϫ3.29 (P Ͻ 0.05; Kaessmann et al. 1999; see Zhao et al. 2000 for new computation of Tajima's D). Zhao et al. (2000) concluded that the rejection of neutrality in this region might indicate linkage of this noncoding region to a gene under selection. Xq13.3 10 kb region is 1 Mb apart from PGK-1, the closest gene, and 1.3 Mb apart from PGAM3, the gene studied here. The high rate of amino acid substitution we present exists in PGAM3, indicating that PGAM3 has been under positive selection in the human lineage. Because PGAM3 is located in the Xq13.3 region that shows very low recombination (Kaessmann et al. 1999) , it is conceivable that rapid fixation events in this gene contributed to sweep variation away in that part of the genome (as observed; Kaessmann et al. 1999; Zhao et al. 2000 for new computations).
PGAM3 Function
Although no transcript was observed for this gene by Dierick, Mercer, and Glover (1997) , they already pointed out that the region upstream of the gene shows some features of possible promoter region (TATA box and CAAT box). Here, we report preliminary data on the expression of PGAM3 in white blood cells, suggesting that mRNA is produced and that the protein can be produced in some tissues. We know that the three amino acids in the active center of the PGAM proteins are intact in PGAM3 in human and chimpanzee. This reveals that it is likely that the putative PGAM3 retains PGAM activity.
We have studied the evolution of Phosphoglycerate mutase 3 processed gene (PGAM3) that was previously believed to be a pseudogene (Dierick, Mercer, and Glover 1997) . However, polymorphism and divergence data as well as expression analysis support its functionality. Interestingly, many amino acid substitutions took place in PGAM3 in a short period of time. This suggests a scenario in which this gene could be gaining a new function in the genomes of human and chimpanzee.
The estimated amount of processed copies of genes in the human genome is large. Different pseudogenes might be in different stages: recent acquisitions (Mighell et al. 2000) , old acquisitions (Vanin 1985) , recent loss of function (Winter et al. 2001) , recent regain of function (Mighell et al. 2000) , or functional throughout its evolution (Brosius 1999) . Some of them might be pseudogenes following the expected pattern for nonfunctional sequences, but some others might be an important source of new genes. The evolutionary and functional analyses as presented in this investigation may be an efficient approach to revealing the evolutionary processes of these processed genes.
Supplementary Material
The PGAM1 and PGAM2 (phosphoglycerate mutase muscle isoform gene; Dierick et al. 1995) sequences used in the analysis were retrieved from GenBank (accession numbers NM002629 and XM011580, respectively). New sequences have been submitted to GenBank under accession numbers AF465731-46.
